HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

F J Gonzalez Selected Research

Peroxisome Proliferators

6/2001Evidence that reduction of hepatocyte growth factor (HGF) is not required for peroxisome proliferator-induced hepatocyte proliferation.
4/2001Phthalates rapidly increase production of reactive oxygen species in vivo: role of Kupffer cells.
9/2000Evidence for peroxisome proliferator-activated receptor (PPAR)alpha-independent peroxisome proliferation: effects of PPARgamma/delta-specific agonists in PPARalpha-null mice.
4/2000Peroxisome proliferator-activated receptor alpha is restricted to hepatic parenchymal cells, not Kupffer cells: implications for the mechanism of action of peroxisome proliferators in hepatocarcinogenesis.
3/2000Suppression of mouse hepatocyte apoptosis by peroxisome proliferators: role of PPARalpha and TNFalpha.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


F J Gonzalez Research Topics

Disease

12Neoplasms (Cancer)
09/2010 - 04/2000
11Carcinogenesis
11/2014 - 03/2000
5Necrosis
08/2006 - 02/2000
4Body Weight (Weight, Body)
04/2011 - 10/2001
4Inflammation (Inflammations)
08/2006 - 07/2000
4Hepatomegaly
12/2001 - 03/2001
3Insulin Resistance
04/2011 - 10/2001
3Ischemia
10/2008 - 04/2000
2Hypertension (High Blood Pressure)
04/2008 - 12/2000
2Alcoholic Liver Diseases (Alcoholic Liver Disease)
12/2001 - 04/2000
2Weight Gain
10/2001 - 10/2001
1Respiratory Tract Diseases (Respiratory Tract Disease)
03/2018
1Pulmonary Fibrosis (Fibrosing Alveolitis)
03/2018
1Asthma (Bronchial Asthma)
07/2011
1Rhinitis
07/2011
1Congenital Abnormalities (Deformity)
09/2010
1Chronic Obstructive Pulmonary Disease (COPD)
01/2010
1Cardiovascular Diseases (Cardiovascular Disease)
10/2008
1Cardiomegaly (Heart Hypertrophy)
04/2008
1Hemorrhage
08/2006
1Colitis
08/2006
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
08/2006
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2006
1Type 2 Diabetes Mellitus (MODY)
08/2002
1Type 3 Maturity-Onset Diabetes of the Young
08/2002
1Liver Diseases (Liver Disease)
12/2001
1Hypoglycemia (Reactive Hypoglycemia)
12/2001
1Hyperglycemia
12/2001
1Aberrant Crypt Foci
12/2001
1Drug-Related Side Effects and Adverse Reactions
11/2001
1Obesity
10/2001
1Wounds and Injuries (Trauma)
08/2001
1Hypercholesterolemia
04/2001
1Hyperlipidemias (Hyperlipidemia)
03/2001
1Glycogen Storage Disease (Glycogenosis)
03/2001
1Hepatocellular Carcinoma (Hepatoma)
02/2001

Drug/Important Bio-Agent (IBA)

9PPAR alphaIBA
12/2001 - 04/2000
6EnzymesIBA
12/2001 - 04/2000
5Peroxisome ProliferatorsIBA
06/2001 - 03/2000
3Peroxisome Proliferator-Activated Receptors (PPAR)IBA
11/2014 - 10/2001
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2011 - 07/2004
3LigandsIBA
08/2006 - 12/2001
3PPAR-betaIBA
01/2006 - 07/2000
3Proteins (Proteins, Gene)FDA Link
08/2002 - 07/2000
3Cytochrome P-450 CYP2E1 (CYP2E1)IBA
12/2001 - 04/2000
3pirinixic acidIBA
10/2001 - 04/2000
3XenobioticsIBA
06/2001 - 09/2000
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2000 - 02/2000
2Triglycerides (Triacylglycerol)IBA
04/2011 - 10/2001
2Glucose (Dextrose)FDA LinkGeneric
04/2011 - 12/2001
2Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
04/2008 - 10/2000
2Thrombospondin 1IBA
07/2004 - 07/2004
2Hepatocyte Nuclear Factor 1-alpha (Hepatocyte Nuclear Factor 1 alpha)IBA
08/2002 - 03/2001
2Oxidants (Oxidizing Agents)IBA
12/2001 - 04/2001
2Ethanol (Ethyl Alcohol)IBA
12/2001 - 10/2000
2Fatty Acids (Saturated Fatty Acids)IBA
12/2001 - 07/2000
2Insulin (Novolin)FDA Link
12/2001 - 10/2001
2DNA (Deoxyribonucleic Acid)IBA
12/2001 - 03/2000
2CarcinogensIBA
12/2001 - 06/2001
2LipidsIBA
10/2001 - 10/2001
2anthraceneIBA
03/2001 - 07/2000
2Cytochrome P-450 CYP1A2 (CYP1A2)IBA
09/2000 - 01/2000
1Polychlorinated Dibenzodioxins (TCDD)IBA
09/2010
1Aromatic HydrocarbonsIBA
09/2010
1Transcription Factors (Transcription Factor)IBA
01/2010
1CCAAT-Enhancer-Binding Protein-alphaIBA
01/2010
1CCAAT-Enhancer-Binding ProteinsIBA
01/2010
1erucylphosphocholineIBA
10/2008
1Erlotinib Hydrochloride (CP 358,774)FDA Link
05/2008
1BAS 100IBA
05/2008
1Adrenergic Receptors (Adrenergic Receptor)IBA
04/2008
1Angiotensin IIIBA
04/2008
1Messenger RNA (mRNA)IBA
08/2006
1CytokinesIBA
08/2006
1Dextrans (Dextran)FDA Link
08/2006
1InterleukinsIBA
08/2006
1SodiumIBA
08/2006
1PPAR gammaIBA
08/2006
1Rosiglitazone (Avandia)FDA Link
08/2006
1Hepatocyte Nuclear FactorsIBA
08/2002
1Free RadicalsIBA
12/2001
1Bile Acids and Salts (Bile Acids)IBA
12/2001
1Blood Glucose (Blood Sugar)IBA
12/2001
1GuanineIBA
12/2001
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
11/2001
1Pharmaceutical PreparationsIBA
11/2001
1Insulin-Like Growth Factor Binding Protein 1IBA
10/2001
1Biological ProductsIBA
06/2001
1Glutathione Transferase (Glutathione S-Transferase)IBA
05/2001
1XanthineIBA
05/2001
1OligonucleotidesIBA
04/2001
1Glucose-6-Phosphatase (Glucose 6 Phosphatase)IBA
03/2001
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
02/2001
1Epoxide HydrolasesIBA
12/2000
1isopentyl alcoholIBA
10/2000
1Acetaminophen (Paracetamol)FDA LinkGeneric
10/2000

Therapy/Procedure

2Therapeutics
07/2011 - 10/2008
1Lung Transplantation
03/2018
1Liver Transplantation
05/2001
1Warm Ischemia
05/2001